Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
13F holders, Q4 2024
Institutional positions in Abvc Biopharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- +4 vs. Q3 2024
- Shares held
- 409.2K
- +181.1K (+79.4%) vs. Q3 2024
- Total value
- $241.0K
- +$85.2K (+54.7%) vs. Q3 2024
- New holders
- 4
- 5 more added
- Sold out
- 0
- 1 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $1.72M |
| Q1 2026 | 13 | $792.1K |
| Q4 2025 | 14 | $1.82M |
| Q3 2025 | 14 | $2.39M |
| Q2 2025 | 9 | $817.4K |
| Q1 2025 | 10 | $304.7K |
| Q4 2024 | 13 | $241.0K |
| Q3 2024 | 9 | $155.9K |
| Q2 2024 | 11 | $170.6K |
| Q1 2024 | 8 | $332.6K |
| Q4 2023 | 8 | $128.5K |
| Q3 2023 | 9 | $79.8K |
| Q2 2023 | 9 | $304.2K |
| Q1 2023 | 9 | $421.1K |
| Q4 2022 | 9 | $377.0K |
| Q3 2022 | 11 | $571.0K |
| Q2 2022 | 5 | $1.66M |
| Q1 2022 | 4 | $1.17M |
| Q4 2021 | 5 | $1.56M |
| Q3 2021 | 9 | $521.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Abvc Biopharma, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avantax Planning Partners, Inc. | 143,968 | $84.9K | 0.00% | +104,968+269.1% | Added |
| Geode Capital Management, LLC | 79,285 | $46.8K | 0.00% | +7,678+10.7% | Added |
| Vanguard Group Inc | 46,947 | $27.7K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 40,743 | $24.0K | 0.00% | +40,743 | New |
| XTX Topco Ltd | 34,405 | $20.3K | 0.00% | +11,000+47.0% | Added |
| Northern Trust Corp | 19,135 | $11.3K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,935 | $9.00K | 0.00% | +15,935 | New |
| State Street Corp | 12,900 | $7.61K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 12,593 | $7.43K | 0.00% | +196+1.6% | Added |
| Tower Research Capital LLC (TRC) | 2,563 | $1.51K | 0.00% | −60−2.3% | Reduced |
| SBI Securities Co., Ltd. | 662 | $391 | 0.00% | +662 | New |
| Bank of America Corp | 81 | $48 | 0.00% | +3+3.8% | Added |
| UBS Group AG | 10 | $6 | 0.00% | +10 | New |